世界のデジタルPCR(dPCR)・リアルタイムPCR(qPCR)市場予測(~2025年):製品別(機器、試薬・消耗品、ソフトウェア・サービス)、用途別(臨床、研究、法医学)、エンドユーザー別(病院・診断センター、製薬バイオテクノロジー、CRO)

◆英語タイトル:Digital PCR (dPCR) and Real-time PCR (qPCR) Market by Product (Instruments, Reagents & Consumables, Software & Services), Application (Clinical, Research, Forensic), End User (Hospitals & Diagnostic Centers, Pharma Biotech, CROs) - Global Forecast to 2025
◆商品コード:BT3161
◆発行会社(リサーチ会社):MarketsandMarkets
◆発行日:2021年3月4日
◆ページ数:307
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥564,300見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥758,100見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥929,100見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarkets社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
MarketsandMarkets社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

マーケッツアンドマーケッツ社は世界のデジタルPCR(dPCR)・リアルタイムPCR(qPCR)市場規模が2020年49億ドルから2025年76億ドルまで、年平均9.0%成長すると予想しています。本市場調査資料では、デジタルPCR(dPCR)・リアルタイムPCR(qPCR)の世界市場を広く調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、製品・サービス別(試薬・消耗品、機器、ソフトウェア・サービス)分析、用途別(臨床用、研究用、法医学用)分析、エンドユーザー別(病院・診断センター、研究所・学術機関、製薬・バイオテクノロジー企業、臨床研究機関、法医学研究所)分析、地域別分析、競争状況、企業情報、隣接関連市場などを掲載しています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・世界のデジタルPCR(dPCR)・リアルタイムPCR(qPCR)市場規模:製品・サービス別(試薬・消耗品、機器、ソフトウェア・サービス)
・世界のデジタルPCR(dPCR)・リアルタイムPCR(qPCR)市場規模:用途別(臨床用、研究用、法医学用)
・世界のデジタルPCR(dPCR)・リアルタイムPCR(qPCR)市場規模:エンドユーザー別(病院・診断センター、研究所・学術機関、製薬・バイオテクノロジー企業、臨床研究機関、法医学研究所)
・世界のデジタルPCR(dPCR)・リアルタイムPCR(qPCR)市場規模:地域別
・競争状況
・企業情報
・隣接関連市場
【レポートの概要】

“The global dPCR and qPCR market size is projected to reach USD 7.6 billion by 2025 from USD 4.9 billion in 2020, at a CAGR of 9.0%.”
The growth of this market is driven majorly by factors such as the rising incidence of target infectious diseases and genetic disorders; technological advancements in PCR technologies; increasing investments, funds, and grants; increasing use of biomarker profiling for disease diagnostics; and successful completion of the Human Genome Project. On the other hand, high instrument costs—especially that of dPCR—and the technical limitations of PCR are restraining market growth.

“By application, the clinical applications segment (of qPCR) is expected to grow at the highest CAGR during the forecast period.”
Based on application, the qPCR market is segmented into clinical applications, research applications, and forensic applications. The clinical applications segment is expected to register the highest growth during the forecast period. The key factors driving the market growth include the growing usage of qPCR in disease diagnosis, rising incidence of infectious & genetic diseases, and growing public emphasis on early & effective disease diagnosis & treatment.

“By end-user, the hospitals and diagnostics centers segment dominated the dPCR market in 2019.”
Based on end-user, the dPCR market is segmented into Hospitals and Diagnostic Centers, Research Laboratories and Academic Institutes, Pharmaceutical and Biotechnology Companies, Clinical Research Organizations, and Forensic Laboratories. The Hospitals and Diagnostic Centers segment accounted for the largest share of the dPCR market in 2019, primarily due to the growing demand for early and efficient disease diagnosis and treatment, increasing number of dPCR product launches for diagnostic applications, benefits offered by dPCR in disease diagnosis (as compared to other PCR technologies), and growing public awareness related to the benefits offered by dPCR in disease diagnosis.

“Asia Pacific dPCR and qPCR market is expected to witness the highest growth during the forecast period.”
The Asia Pacific market is estimated to grow at the highest CAGR during the forecast period, primarily due to the ongoing expansion & modernization of the healthcare infrastructure in emerging Asian countries; increasing number of research projects in China, India, and Japan in the field of genomics and cancer; the rising trend of clinical research being outsourced to Asia-based CROs by leading drug manufacturing companies; and continuous government support for genomics-based research activities in emerging Asia Pacific countries.

A breakdown of the primary participants referred to for this report is provided below:
• By Company Type: Tier 1–45%, Tier 2–34%, and Tier 3–21%
• By Designation: D-level–14%, C-level–10%, and Others–78%
• By Region: North America–31%, Europe–33%, Asia Pacific–19%, RoW-18%

Thermo Fisher Scientific (US), Bio-Rad Laboratories Inc. (US), and F. Hoffmann-La Roche, Ltd. (Switzerland) are the key players operating in this market. Other prominent players are Abbott Laboratories (US), Agilent Technologies (US), Analytik Jena AG (Switzerland), Becton Dikinson and Company (US), bioMérieux SA (France), Danaher Corporation (US), Eppendorf (Germany), Fluidigm Corporation (US), Merck KGaA (Germany), QIAGEN N.V. (Netherlands), Takara Bio (Japan), Meridian Bioscience (US), Promega Corporation (US), Enzo Life Sciences, Inc. (US), Bioneer (South Korea), ELITech Group (France), and Quidel Corporation (US).

Research Coverage:
The report analyzes the dPCR and qPCR market and aims at estimating the market size and future growth potential. The report also includes an in-depth competitive analysis of the key players in this market, along with their company profiles, product offerings, and recent developments.

Reasons to Buy the Report:
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a more significant share. Firms purchasing the report could use one, or a combination of the below mentioned five strategies for strengthening their market presence.

This report provides insights on the following pointers:
• Market Penetration: Comprehensive information on the product portfolios offered by the top players in the dPCR and qPCR market
• Service Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the dPCR and qPCR market
• Market Development: Comprehensive information on lucrative emerging regions
• Market Diversification: Exhaustive information about new systems, growing geographies, and recent developments in the global dPCR and qPCR market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, revenue analysis, and services of leading players in the dPCR and qPCR market

【レポートの目次】

1 INTRODUCTION 35
1.1 OBJECTIVES OF THE STUDY 35
1.2 MARKET DEFINITION 35
1.2.1 INCLUSIONS AND EXCLUSIONS 35
1.3 STUDY SCOPE 36
1.3.1 MARKETS COVERED 36
1.3.2 YEARS CONSIDERED FOR THE STUDY 37
1.4 CURRENCY USED FOR THE STUDY 37
1.5 LIMITATIONS 37
1.6 MARKET STAKEHOLDERS 38
1.7 SUMMARY OF CHANGES 38
FIGURE 1 THE MARKET FOR DPCR AND QPCR IS EXPECTED TO WITNESS ROBUST GROWTH DURING THE FORECAST PERIOD, COMPARED WITH THE PREVIOUS ESTIMATES OF THIS MARKET 38
2 RESEARCH METHODOLOGY 40
2.1 RESEARCH DATA 40
FIGURE 2 RESEARCH DESIGN 40
2.1.1 SECONDARY DATA 41
2.1.1.1 Key secondary sources 42
2.1.2 PRIMARY DATA 43
2.1.2.1 Key data from primary sources 43
2.1.2.2 Breakdown of primaries 44
2.2 MARKET ESTIMATION METHODOLOGY 44
FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 45
2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION 45
2.2.2 USAGE-BASED MARKET ESTIMATION 46
FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: GLOBAL DPCR AND QPCR MARKET 46
2.2.3 GROWTH FORECAST 47
2.2.4 GEOGRAPHIC MARKET ASSESSMENT (BY REGION & COUNTRY) 47
2.2.5 PRIMARY RESEARCH VALIDATION 47
2.3 DATA TRIANGULATION 48
FIGURE 5 DATA TRIANGULATION 48
2.4 RESEARCH ASSUMPTIONS 49
2.5 RISK ANALYSIS 49

3 EXECUTIVE SUMMARY 50
FIGURE 6 GLOBAL QPCR PRODUCTS & SERVICES MARKET, BY TYPE,
2020 VS. 2025 (USD MILLION) 51
FIGURE 7 GLOBAL DPCR PRODUCTS & SERVICES MARKET, BY TYPE,
2020 VS. 2025 (USD MILLION) 52
FIGURE 8 GLOBAL QPCR MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION) 53
FIGURE 9 GLOBAL DPCR MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION) 54
FIGURE 10 DPCR AND QPCR MARKET: GEOGRAPHIC SNAPSHOT 55
4 PREMIUM INSIGHTS 57
4.1 GLOBAL DPCR AND QPCR MARKET OVERVIEW 57
FIGURE 11 RISING INCIDENCE OF TARGET INFECTIOUS DISEASES AND GENETIC DISORDERS IS EXPECTED TO DRIVE MARKET GROWTH 57
4.2 NORTH AMERICAN DPCR MARKET, BY REGION, 2020 VS. 2025 (USD MILLION) 58
FIGURE 12 NORTH AMERICA IS EXPECTED TO DOMINATE THE DPCR MARKET DURING THE FORECAST PERIOD 58
4.3 GEOGRAPHICAL SNAPSHOT OF THE DPCR AND QPCR MARKET 59
FIGURE 13 ASIA PACIFIC TO WITNESS HIGHEST GROWTH DURING THE FORECAST PERIOD 59
5 MARKET OVERVIEW 60
5.1 INTRODUCTION 60
5.2 MARKET DYNAMICS 60
FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 60
5.2.1 KEY MARKET DRIVERS 61
5.2.1.1 Rising incidence of target infectious diseases and genetic disorders 61
FIGURE 15 GLOBAL BURDEN OF HIV INFECTIONS, BY REGION, 2019 61
FIGURE 16 GROWING GERIATRIC POPULATION ACROSS KEY REGIONS (2017 VS. 2030) 62
5.2.1.2 Technological advancements in PCR technologies 62
FIGURE 17 TRADITIONAL PCR VS. QPCR AND DPCR: A COMPARATIVE STUDY 63
5.2.1.3 Increasing investments, funds, and grants 63
5.2.1.4 Increasing use of biomarker profiling for disease diagnostics 64
5.2.1.5 Successful completion of the Human Genome Project 65
5.2.2 KEY MARKET RESTRAINTS 65
5.2.2.1 High device costs associated with dPCR 65
5.2.2.2 Technical limitations of qPCR and dPCR techniques 65
5.2.3 KEY MARKET OPPORTUNITIES 66
5.2.3.1 Growing market penetration in emerging countries 66
5.2.3.2 Shift from plant-derived to genome-based drug discovery 66
5.2.4 KEY MARKET CHALLENGES 67
5.2.4.1 Adoption and implementation of MIQE guidelines 67
5.2.5 KEY MARKET TRENDS 67
5.2.5.1 Development of compact, portable, and lab-on-chip PCR devices 67
5.2.5.2 Ongoing technological integration with the PCR process 68
5.3 COVID-19 IMPACT ON THE DIGITAL PCR (DPCR) AND REAL-TIME PCR (QPCR) MARKET 68
6 DPCR AND QPCR MARKET, BY PRODUCT & SERVICE 69
6.1 INTRODUCTION 70
TABLE 1 DPCR AND QPCR MARKET, BY TECHNOLOGY, 2016–2019 (USD MILLION) 70
TABLE 2 DPCR AND QPCR MARKET, BY TECHNOLOGY, 2020–2025 (USD MILLION) 70
6.2 QPCR PRODUCTS & SERVICES 71
TABLE 3 QPCR PRODUCTS & SERVICES MARKET, BY TYPE,
2016–2019 (USD MILLION) 71
TABLE 4 QPCR PRODUCTS & SERVICES MARKET, BY TYPE,
2020–2025 (USD MILLION) 72
TABLE 5 QPCR PRODUCTS & SERVICES MARKET, BY REGION,
2016–2019 (USD MILLION) 72
TABLE 6 QPCR PRODUCTS & SERVICES MARKET, BY REGION,
2020–2025 (USD MILLION) 73
6.2.1 QPCR REAGENTS AND CONSUMABLES 73
TABLE 7 QPCR REAGENTS AND CONSUMABLES MARKET, BY REGION,
2016–2019 (USD MILLION) 74
TABLE 8 QPCR REAGENTS AND CONSUMABLES MARKET, BY REGION,
2020–2025 (USD MILLION) 74
6.2.1.1 qPCR reagents and consumables market, by application 75
TABLE 9 QPCR REAGENTS AND CONSUMABLES MARKET, BY APPLICATION,
2016–2019 (USD MILLION) 75
TABLE 10 QPCR REAGENTS AND CONSUMABLES MARKET, BY APPLICATION,
2020–2025 (USD MILLION) 75
6.2.1.2 qPCR reagents and consumables market, by end user 76
TABLE 11 QPCR REAGENTS AND CONSUMABLES MARKET, BY END USER,
2016–2019 (USD MILLION) 76
TABLE 12 QPCR REAGENTS AND CONSUMABLES MARKET, BY END USER,
2020–2025 (USD MILLION) 76
6.2.2 QPCR INSTRUMENTS 77
TABLE 13 QPCR INSTRUMENTS MARKET, BY REGION, 2016–2019 (USD MILLION) 77
TABLE 14 QPCR INSTRUMENTS MARKET, BY REGION, 2020–2025 (USD MILLION) 78
6.2.2.1 qPCR instruments market, by application 78
TABLE 15 QPCR INSTRUMENTS MARKET, BY APPLICATION, 2016–2019 (USD MILLION) 78
TABLE 16 QPCR INSTRUMENTS MARKET, BY APPLICATION, 2020–2025 (USD MILLION) 79
6.2.2.2 qPCR instruments market, by end user 79
TABLE 17 QPCR INSTRUMENTS MARKET, BY END USER, 2016–2019 (USD MILLION) 79
TABLE 18 QPCR INSTRUMENTS MARKET, BY END USER, 2020–2025 (USD MILLION) 80
6.2.3 QPCR SOFTWARE AND SERVICES 80
TABLE 19 QPCR SOFTWARE AND SERVICES MARKET, BY REGION,
2016–2019 (USD MILLION) 80
TABLE 20 QPCR SOFTWARE AND SERVICES MARKET, BY REGION,
2020–2025 (USD MILLION) 81
6.2.3.1 qPCR software and services market, by application 81
TABLE 21 QPCR SOFTWARE AND SERVICES MARKET, BY APPLICATION,
2016–2019 (USD MILLION) 81
TABLE 22 QPCR SOFTWARE AND SERVICES MARKET, BY APPLICATION,
2020–2025 (USD MILLION) 82
6.2.3.2 qPCR software and services market, by end user 82
TABLE 23 QPCR SOFTWARE AND SERVICES MARKET, BY END USER,
2016–2019 (USD MILLION) 82
TABLE 24 QPCR SOFTWARE AND SERVICES MARKET, BY END USER,
2020–2025 (USD MILLION) 83
6.3 DPCR PRODUCTS & SERVICES 83
TABLE 25 DPCR PRODUCTS & SERVICES MARKET, BY TYPE,
2016–2019 (USD MILLION) 84
TABLE 26 DPCR PRODUCTS & SERVICES MARKET, BY TYPE,
2020–2025 (USD MILLION) 84
TABLE 27 DPCR PRODUCTS & SERVICES MARKET, BY REGION,
2016–2019 (USD MILLION) 85
TABLE 28 DPCR PRODUCTS & SERVICES MARKET, BY REGION,
2020–2025 (USD MILLION) 85
6.3.1 DPCR INSTRUMENTS 86
TABLE 29 DPCR INSTRUMENTS MARKET, BY REGION, 2016–2019 (USD MILLION) 87
TABLE 30 DPCR INSTRUMENTS MARKET, BY REGION, 2020–2025 (USD MILLION) 87
6.3.1.1 dPCR instruments market, by application 88
TABLE 31 DPCR INSTRUMENTS MARKET, BY APPLICATION, 2016–2019 (USD MILLION) 88
6.3.1.2 dPCR instruments market, by application 88
TABLE 32 DPCR INSTRUMENTS MARKET, BY APPLICATION, 2020–2025 (USD MILLION) 88
6.3.1.3 dPCR instruments market, by end user 89
TABLE 33 DPCR INSTRUMENTS MARKET, BY END USER, 2016–2019 (USD MILLION) 89
TABLE 34 DPCR INSTRUMENTS MARKET, BY END USER, 2020–2025 (USD MILLION) 89
6.3.2 DPCR REAGENTS AND CONSUMABLES 90
TABLE 35 DPCR REAGENTS AND CONSUMABLES MARKET, BY REGION,
2016–2019 (USD MILLION) 90
TABLE 36 DPCR REAGENTS AND CONSUMABLES MARKET, BY REGION,
2020–2025 (USD MILLION) 91
6.3.2.1 dPCR reagents and consumables market, by application 91
TABLE 37 DPCR REAGENTS AND CONSUMABLES MARKET, BY APPLICATION,
2016–2019 (USD MILLION) 91
TABLE 38 DPCR REAGENTS AND CONSUMABLES MARKET, BY APPLICATION,
2020–2025 (USD MILLION) 92
6.3.2.2 dPCR reagents and consumables market, by end user 92
TABLE 39 DPCR REAGENTS AND CONSUMABLES MARKET, BY END USER,
2016–2019 (USD MILLION) 92
TABLE 40 DPCR REAGENTS AND CONSUMABLES MARKET, BY END USER,
2020–2025 (USD MILLION) 93
6.3.3 DPCR SOFTWARE AND SERVICES 93
TABLE 41 DPCR SOFTWARE AND SERVICES MARKET, BY REGION,
2016–2019 (USD MILLION) 94
TABLE 42 DPCR SOFTWARE AND SERVICES MARKET, BY REGION,
2020–2025 (USD MILLION) 94
6.3.3.1 dPCR software and services market, by application 95
TABLE 43 DPCR SOFTWARE AND SERVICES MARKET, BY APPLICATION,
2016–2019 (USD MILLION) 95
6.3.3.2 dPCR software and services market, by application 95
TABLE 44 DPCR SOFTWARE AND SERVICES MARKET, BY APPLICATION,
2020–2025 (USD MILLION) 95
6.3.3.3 dPCR software and services market, by end user 96
TABLE 45 DPCR SOFTWARE AND SERVICES MARKET, BY END USER,
2016–2019 (USD MILLION) 96
TABLE 46 DPCR SOFTWARE AND SERVICES MARKET, BY END USER,
2020–2025 (USD MILLION) 96
7 DPCR AND QPCR MARKET, BY APPLICATION 97
7.1 INTRODUCTION 98
7.2 QPCR APPLICATIONS 98
TABLE 47 GLOBAL QPCR MARKET, BY APPLICATION, 2016–2019 (USD MILLION) 98
TABLE 48 GLOBAL QPCR MARKET, BY APPLICATION, 2020–2025 (USD MILLION) 98
7.2.1 CLINICAL APPLICATIONS 99
TABLE 49 GLOBAL QPCR CLINICAL APPLICATIONS MARKET, BY TYPE,
2016–2019 (USD MILLION) 99
TABLE 50 GLOBAL QPCR CLINICAL APPLICATIONS MARKET, BY TYPE,
2020–2025 (USD MILLION) 100
TABLE 51 QPCR CLINICAL APPLICATIONS MARKET, BY REGION,
2016–2019 (USD MILLION) 100
TABLE 52 QPCR CLINICAL APPLICATIONS MARKET, BY REGION,
2020–2025 (USD MILLION) 101
7.2.1.1 Infectious disease testing 101
7.2.1.1.1 The wide availability of qPCR assays and kits for infectious disease testing is a key factor driving market growth 101
TABLE 53 QPCR CLINICAL APPLICATIONS MARKET FOR INFECTIOUS DISEASE TESTING, BY REGION, 2016–2019 (USD MILLION) 102
TABLE 54 QPCR CLINICAL APPLICATIONS MARKET FOR INFECTIOUS DISEASE TESTING, BY REGION, 2020–2025 (USD MILLION) 102
7.2.1.2 Oncology testing 103
7.2.1.2.1 The advent of alternative diagnostic technologies for oncology testing is a key factor restraining market growth 103
TABLE 55 QPCR CLINICAL APPLICATIONS MARKET FOR ONCOLOGY TESTING,
BY REGION, 2016–2019 (USD MILLION) 103
TABLE 56 QPCR CLINICAL APPLICATIONS MARKET FOR ONCOLOGY TESTING,
BY REGION, 2020–2025 (USD MILLION) 104
7.2.1.3 Blood screening 104
7.2.1.3.1 The elimination of post-amplification processing and easy process automation to drive the demand for qPCR products 104
TABLE 57 QPCR CLINICAL APPLICATIONS MARKET FOR BLOOD SCREENING,
BY REGION, 2016–2019 (USD MILLION) 105
TABLE 58 QPCR CLINICAL APPLICATIONS MARKET FOR BLOOD SCREENING,
BY REGION, 2020–2025 (USD MILLION) 105
7.2.1.4 Transplant diagnostics 106
7.2.1.4.1 Increasing commercialization of qPCR products for transplant diagnostics to drive the market growth 106
TABLE 59 QPCR CLINICAL APPLICATIONS MARKET FOR TRANSPLANT DIAGNOSTICS,
BY REGION, 2016–2019 (USD MILLION) 106
TABLE 60 QPCR CLINICAL APPLICATIONS MARKET FOR TRANSPLANT DIAGNOSTICS,
BY REGION, 2020–2025 (USD MILLION) 107
7.2.1.5 Other clinical applications 107
TABLE 61 QPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY REGION,
2016–2019 (USD MILLION) 107
TABLE 62 QPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY REGION,
2020–2025 (USD MILLION) 108
7.2.2 RESEARCH APPLICATIONS 108
7.2.2.1 Increase in genome-based research activity boosts the market growth 108
TABLE 63 QPCR RESEARCH APPLICATIONS MARKET, BY REGION,
2016–2019 (USD MILLION) 109
TABLE 64 QPCR RESEARCH APPLICATIONS MARKET, BY REGION,
2020 –2025 (USD MILLION) 109
7.2.3 FORENSIC APPLICATIONS 110
7.2.3.1 Limited adoption of qPCR in underdeveloped and developing countries is expected to restrict the market growth 110
TABLE 65 QPCR FORENSIC APPLICATIONS MARKET, BY REGION,
2016–2019 (USD MILLION) 110
TABLE 66 QPCR FORENSIC APPLICATIONS MARKET, BY REGION,
2020–2025 (USD MILLION) 111
7.3 DPCR APPLICATIONS 111
TABLE 67 GLOBAL DPCR MARKET, BY APPLICATION, 2016–2019 (USD MILLION) 111
TABLE 68 GLOBAL DPCR MARKET, BY APPLICATION, 2020–2025 (USD MILLION) 112
7.3.1 CLINICAL APPLICATIONS 112
TABLE 69 GLOBAL DPCR CLINICAL APPLICATIONS MARKET, BY TYPE,
2016–2019 (USD MILLION) 112
TABLE 70 GLOBAL DPCR CLINICAL APPLICATIONS MARKET, BY TYPE,
2020–2025 (USD MILLION) 113
TABLE 71 DPCR CLINICAL APPLICATIONS MARKET, BY REGION,
2016–2019 (USD MILLION) 113
TABLE 72 DPCR CLINICAL APPLICATIONS MARKET, BY REGION,
2020–2025 (USD MILLION) 114
7.3.1.1 Infectious disease testing 114
7.3.1.1.1 Accuracy and precision of dPCR have made it a prominent tool in infectious disease testing 114
TABLE 73 DPCR CLINICAL APPLICATIONS MARKET FOR INFECTIOUS DISEASE TESTING, BY REGION, 2016–2019 (USD MILLION) 115
TABLE 74 DPCR CLINICAL APPLICATIONS MARKET FOR INFECTIOUS DISEASE TESTING, BY REGION, 2020–2025 (USD MILLION) 115
7.3.1.2 Oncology testing 116
7.3.1.2.1 dPCR plays a vital role in oncology testing and clinical studies 116
TABLE 75 DPCR CLINICAL APPLICATIONS MARKET FOR ONCOLOGY TESTING,
BY REGION, 2016–2019 (USD MILLION) 116
TABLE 76 DPCR CLINICAL APPLICATIONS MARKET FOR ONCOLOGY TESTING,
BY REGION, 2020–2025 (USD MILLION) 117
7.3.1.3 Blood screening 117
7.3.1.3.1 dPCR offers multiple advantages over traditional techniques for blood screening 117
TABLE 77 DPCR CLINICAL APPLICATIONS MARKET FOR BLOOD SCREENING,
BY REGION, 2016–2019 (USD MILLION) 118
TABLE 78 DPCR CLINICAL APPLICATIONS MARKET FOR BLOOD SCREENING,
BY REGION, 2020–2025 (USD MILLION) 118
7.3.1.4 Transplant diagnostics 119
7.3.1.4.1 Low market availability of dPCR products for transplant diagnostics to reflect in the small share of this segment 119
TABLE 79 DPCR CLINICAL APPLICATIONS MARKET FOR TRANSPLANT DIAGNOSTICS,
BY REGION, 2016–2019 (USD MILLION) 119
TABLE 80 DPCR CLINICAL APPLICATIONS MARKET FOR TRANSPLANT DIAGNOSTICS,
BY REGION, 2020–2025 (USD MILLION) 120
7.3.1.5 Other clinical applications 120
TABLE 81 DPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY REGION,
2016–2019 (USD MILLION) 121
TABLE 82 DPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY REGION,
2020–2025 (USD MILLION) 121
7.3.2 RESEARCH APPLICATIONS 122
7.3.2.1 Wide usage of dPCR in genetic research is the primary driver for market growth 122
TABLE 83 DPCR RESEARCH APPLICATIONS MARKET, BY REGION,
2016–2019 (USD MILLION) 122
TABLE 84 DPCR RESEARCH APPLICATIONS MARKET, BY REGION,
2020–2025 (USD MILLION) 123
7.3.3 FORENSIC APPLICATIONS 123
7.3.3.1 The need to reduce the time & cost of forensic processes is a key factor driving market growth 123
TABLE 85 DPCR FORENSIC APPLICATIONS MARKET, BY REGION,
2016–2019 (USD MILLION) 124
TABLE 86 DPCR FORENSIC APPLICATIONS MARKET, BY REGION,
2020–2025 (USD MILLION) 124
8 DPCR AND QPCR MARKET, BY END USER 125
8.1 INTRODUCTION 126
8.2 QPCR END USERS 126
TABLE 87 QPCR MARKET, BY END USER, 2016–2019 (USD MILLION) 126
TABLE 88 QPCR MARKET, BY END USER, 2020–2025 (USD MILLION) 127
8.2.1 HOSPITALS AND DIAGNOSTIC CENTERS 127
TABLE 89 QPCR MARKET FOR HOSPITALS AND DIAGNOSTIC CENTERS, BY REGION, 2016–2019 (USD MILLION) 128
TABLE 90 QPCR MARKET FOR HOSPITALS AND DIAGNOSTIC CENTERS, BY REGION, 2020–2025 (USD MILLION) 128
8.2.2 RESEARCH LABORATORIES AND ACADEMIC INSTITUTES 129
TABLE 91 QPCR MARKET FOR RESEARCH LABORATORIES AND ACADEMIC INSTITUTES, BY REGION, 2016–2019 (USD MILLION) 129
TABLE 92 QPCR MARKET FOR RESEARCH LABORATORIES AND ACADEMIC INSTITUTES, BY REGION, 2020–2025 (USD MILLION) 130
8.2.3 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 130
TABLE 93 QPCR MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2016–2019 (USD MILLION) 131
TABLE 94 QPCR MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2020–2025 (USD MILLION) 131
8.2.4 CLINICAL RESEARCH ORGANIZATIONS 132
TABLE 95 QPCR MARKET FOR CLINICAL RESEARCH ORGANIZATIONS, BY REGION, 2016–2019 (USD MILLION) 132
TABLE 96 QPCR MARKET FOR CLINICAL RESEARCH ORGANIZATIONS, BY REGION, 2020–2025 (USD MILLION) 133
8.2.5 FORENSIC LABORATORIES 133
TABLE 97 QPCR MARKET FOR FORENSIC LABORATORIES, BY REGION,
2016–2019 (USD MILLION) 134
TABLE 98 I QPCR MARKET FOR FORENSIC LABORATORIES, BY REGION,
2020–2025 (USD MILLION) 135
8.3 DPCR END USERS 135
TABLE 99 DPCR MARKET, BY END USER, 2016–2019 (USD MILLION) 135
TABLE 100 DPCR MARKET, BY END USER, 2020–2025 (USD MILLION) 136
8.3.1 HOSPITALS AND DIAGNOSTIC CENTERS 136
TABLE 101 DPCR MARKET FOR HOSPITALS AND DIAGNOSTIC CENTERS, BY REGION, 2016–2019 (USD MILLION) 137
TABLE 102 DPCR MARKET FOR HOSPITALS AND DIAGNOSTIC CENTERS, BY REGION, 2020–2025 (USD MILLION) 137
8.3.2 RESEARCH LABORATORIES AND ACADEMIC INSTITUTES 138
TABLE 103 DPCR MARKET FOR RESEARCH LABORATORIES AND ACADEMIC INSTITUTES, BY REGION, 2016–2019 (USD MILLION) 138
TABLE 104 DPCR MARKET FOR RESEARCH LABORATORIES AND ACADEMIC INSTITUTES, BY REGION, 2020–2025 (USD MILLION) 139
8.3.3 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 139
TABLE 105 DPCR MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2016–2019 (USD MILLION) 140
TABLE 106 DPCR MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2020–2025 (USD MILLION) 140
8.3.4 CLINICAL RESEARCH ORGANIZATIONS 141
TABLE 107 DPCR MARKET FOR CLINICAL RESEARCH ORGANIZATIONS, BY REGION, 2016–2019 (USD MILLION) 141
TABLE 108 DPCR MARKET FOR CLINICAL RESEARCH ORGANIZATIONS, BY REGION, 2020–2025 (USD MILLION) 142
8.3.5 FORENSIC LABORATORIES 142
TABLE 109 DPCR MARKET FOR FORENSIC LABORATORIES, BY REGION,
2016–2019 (USD MILLION) 143
TABLE 110 DPCR MARKET FOR FORENSIC LABORATORIES, BY REGION,
2020–2025 (USD MILLION) 143

9 DPCR AND QPCR MARKET, BY REGION 144
9.1 INTRODUCTION 145
TABLE 111 DPCR AND QPCR MARKET, BY REGION, 2016–2019 (USD MILLION) 145
TABLE 112 DPCR AND QPCR MARKET, BY REGION, 2020–2025 (USD MILLION) 146
9.2 NORTH AMERICA 146
FIGURE 18 NORTH AMERICA: DPCR AND QPCR MARKET SNAPSHOT 147
TABLE 113 NORTH AMERICA: QPCR MARKET, BY COUNTRY, 2016–2019 (USD MILLION) 148
TABLE 114 NORTH AMERICA: QPCR MARKET, BY COUNTRY, 2020–2025 (USD MILLION) 148
TABLE 115 NORTH AMERICA: DPCR MARKET, BY COUNTRY, 2016–2019 (USD MILLION) 148
TABLE 116 NORTH AMERICA: DPCR MARKET, BY COUNTRY, 2020–2025 (USD MILLION) 149
TABLE 117 NORTH AMERICA: QPCR MARKET, BY PRODUCT & SERVICE,
2016–2019 (USD MILLION) 149
TABLE 118 NORTH AMERICA: QPCR MARKET, BY PRODUCT & SERVICE,
2020–2025 (USD MILLION) 149
TABLE 119 NORTH AMERICA: DPCR MARKET, BY PRODUCT & SERVICE,
2016–2019 (USD MILLION) 150
TABLE 120 NORTH AMERICA: DPCR MARKET, BY PRODUCT & SERVICE,
2020–2025 (USD MILLION) 150
TABLE 121 NORTH AMERICA: QPCR MARKET, BY APPLICATION,
2016–2019 (USD MILLION) 150
TABLE 122 NORTH AMERICA: QPCR MARKET, BY APPLICATION,
2020–2025 (USD MILLION) 151
TABLE 123 NORTH AMERICA: DPCR MARKET, BY APPLICATION,
2016–2019 (USD MILLION) 151
TABLE 124 NORTH AMERICA: DPCR MARKET, BY APPLICATION,
2020–2025 (USD MILLION) 151
TABLE 125 NORTH AMERICA: QPCR MARKET, BY END USER, 2016–2019 (USD MILLION) 152
TABLE 126 NORTH AMERICA: QPCR MARKET, BY END USER, 2020–2025 (USD MILLION) 152
TABLE 127 NORTH AMERICA: DPCR MARKET, BY END USER, 2016–2019 (USD MILLION) 153
TABLE 128 NORTH AMERICA: DPCR MARKET, BY END USER, 2020–2025 (USD MILLION) 153
9.2.1 US 154
9.2.1.1 The US dominated the North American dPCR and qPCR market
in 2019 154
TABLE 129 US: QPCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION) 154
TABLE 130 US: QPCR MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION) 154
TABLE 131 US: DPCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION) 155
TABLE 132 US: DPCR MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION) 155
9.2.2 CANADA 156
9.2.2.1 Government initiatives for supporting genomics research to drive market growth in Canada 156
TABLE 133 CANADA: QPCR MARKET, BY PRODUCT & SERVICE,
2016–2019 (USD MILLION) 156
TABLE 134 CANADA: QPCR MARKET, BY PRODUCT & SERVICE,
2020–2025 (USD MILLION) 157
TABLE 135 CANADA: DPCR MARKET, BY PRODUCT & SERVICE,
2016–2019 (USD MILLION) 157
TABLE 136 CANADA: DPCR MARKET, BY PRODUCT & SERVICE,
2020–2025 (USD MILLION) 157
9.3 EUROPE 158
TABLE 137 EUROPE: QPCR MARKET, BY COUNTRY, 2016–2019 (USD MILLION) 159
TABLE 138 EUROPE: QPCR MARKET, BY COUNTRY, 2020–2025 (USD MILLION) 159
TABLE 139 EUROPE: DPCR MARKET, BY COUNTRY, 2016–2019 (USD MILLION) 160
TABLE 140 EUROPE: DPCR MARKET, BY COUNTRY, 2020–2025 (USD MILLION) 160
TABLE 141 EUROPE: QPCR MARKET, BY PRODUCT & SERVICE,
2016–2019 (USD MILLION) 161
TABLE 142 EUROPE: QPCR MARKET, BY PRODUCT & SERVICE,
2020–2025 (USD MILLION) 161
TABLE 143 EUROPE: DPCR MARKET, BY PRODUCT & SERVICE,
2016–2019 (USD MILLION) 161
TABLE 144 EUROPE: DPCR MARKET, BY PRODUCT & SERVICE,
2020–2025 (USD MILLION) 162
TABLE 145 EUROPE: QPCR MARKET, BY APPLICATION, 2016–2019 (USD MILLION) 162
TABLE 146 EUROPE: QPCR MARKET, BY APPLICATION, 2020–2025 (USD MILLION) 162
TABLE 147 EUROPE: DPCR MARKET, BY APPLICATION, 2016–2019 (USD MILLION) 163
TABLE 148 EUROPE: DPCR MARKET, BY APPLICATION, 2020–2025 (USD MILLION) 163
TABLE 149 EUROPE: QPCR MARKET, BY END USER, 2016–2019 (USD MILLION) 164
TABLE 150 EUROPE: QPCR MARKET, BY END USER, 2020–2025 (USD MILLION) 164
TABLE 151 EUROPE: DPCR MARKET, BY END USER, 2016–2019 (USD MILLION) 165
TABLE 152 EUROPE: DPCR MARKET, BY END USER, 2020–2025 (USD MILLION) 165
9.3.1 GERMANY 166
9.3.1.1 Germany dominates the European dPCR and qPCR market 166
TABLE 153 GERMANY: QPCR MARKET, BY PRODUCT & SERVICE,
2016–2019 (USD MILLION) 166
TABLE 154 GERMANY: QPCR MARKET, BY PRODUCT & SERVICE,
2020–2025 (USD MILLION) 167
TABLE 155 GERMANY: DPCR MARKET, BY PRODUCT & SERVICE,
2016–2019 (USD MILLION) 167
TABLE 156 GERMANY: DPCR MARKET, BY PRODUCT & SERVICE,
2020–2025 (USD MILLION) 167
9.3.2 UK 168
9.3.2.1 Growing focus on genomics research to support market growth
in the UK 168
TABLE 157 UK: QPCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION) 168
TABLE 158 UK: QPCR MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION) 169
TABLE 159 UK: DPCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION) 169
TABLE 160 UK: DPCR MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION) 169
9.3.3 FRANCE 170
9.3.3.1 Initiatives for developing genomic medicine to support market growth in France 170
TABLE 161 FRANCE: QPCR MARKET, BY PRODUCT & SERVICE,
2016–2019 (USD MILLION) 170
TABLE 162 FRANCE: QPCR MARKET, BY PRODUCT & SERVICE,
2020–2025 (USD MILLION) 171
TABLE 163 FRANCE: DPCR MARKET, BY PRODUCT & SERVICE,
2016–2019 (USD MILLION) 171
TABLE 164 FRANCE: DPCR MARKET, BY PRODUCT & SERVICE,
2020–2025 (USD MILLION) 171
9.3.4 REST OF EUROPE 172
TABLE 165 ROE: QPCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION) 173
TABLE 166 ROE: QPCR MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION) 173
TABLE 167 ROE: DPCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION) 173
TABLE 168 ROE: DPCR MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION) 174
9.4 ASIA PACIFIC 174
FIGURE 19 ASIA PACIFIC: DPCR AND QPCR MARKET SNAPSHOT 175
TABLE 169 APAC: QPCR MARKET, BY COUNTRY, 2016–2019 (USD MILLION) 176
TABLE 170 APAC: QPCR MARKET, BY COUNTRY, 2020–2025 (USD MILLION) 176
TABLE 171 APAC: DPCR MARKET, BY COUNTRY, 2016–2019 (USD MILLION) 177
TABLE 172 APAC: DPCR MARKET, BY COUNTRY, 2020–2025 (USD MILLION) 177
TABLE 173 ASIA PACIFIC: QPCR MARKET, BY PRODUCT & SERVICE,
2016–2019 (USD MILLION) 178
TABLE 174 ASIA PACIFIC: QPCR MARKET, BY PRODUCT & SERVICE,
2020–2025 (USD MILLION) 178
TABLE 175 ASIA PACIFIC: DPCR MARKET, BY PRODUCT & SERVICE,
2016–2019 (USD MILLION) 178
TABLE 176 ASIA PACIFIC: DPCR MARKET, BY PRODUCT & SERVICE,
2020–2025 (USD MILLION) 179
TABLE 177 ASIA PACIFIC: QPCR MARKET, BY APPLICATION, 2016–2019 (USD MILLION) 179
TABLE 178 ASIA PACIFIC: QPCR MARKET, BY APPLICATION, 2020–2025 (USD MILLION) 179
TABLE 179 ASIA PACIFIC: DPCR MARKET, BY APPLICATION, 2016–2019 (USD MILLION) 180
TABLE 180 ASIA PACIFIC: DPCR MARKET, BY APPLICATION, 2020–2025 (USD MILLION) 180
TABLE 181 ASIA PACIFIC: QPCR MARKET, BY END USER, 2016–2019 (USD MILLION) 181
TABLE 182 ASIA PACIFIC: QPCR MARKET, BY END USER, 2020–2025 (USD MILLION) 181
TABLE 183 ASIA PACIFIC: DPCR MARKET, BY END USER, 2016–2019 (USD MILLION) 182
TABLE 184 ASIA PACIFIC: DPCR MARKET, BY END USER, 2020–2025(USD MILLION) 182
9.4.1 JAPAN 183
9.4.1.1 Strong research and healthcare infrastructure to support market growth in Japan 183
TABLE 185 JAPAN: QPCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION) 183
TABLE 186 JAPAN: QPCR MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION) 184
TABLE 187 JAPAN: DPCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION) 184
TABLE 188 JAPAN: DPCR MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION) 184
9.4.2 CHINA 185
9.4.2.1 Healthcare infrastructure modernization to support market growth in China 185
TABLE 189 CHINA: QPCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION) 185
TABLE 190 CHINA: QPCR MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION) 186
TABLE 191 CHINA: DPCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION) 186
TABLE 192 CHINA: DPCR MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION) 186
9.4.3 INDIA 187
9.4.3.1 Presence of a large target patient population to support market growth in India 187
TABLE 193 INDIA: QPCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION) 187
TABLE 194 INDIA: QPCR MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION) 188
TABLE 195 INDIA: DPCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION) 188
TABLE 196 INDIA: DPCR MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION) 188
9.4.4 REST OF APAC 189
TABLE 197 ROAPAC: QPCR MARKET, BY PRODUCT & SERVICE,
2016–2019 (USD MILLION) 189
TABLE 198 ROAPAC: QPCR MARKET, BY PRODUCT & SERVICE,
2020–2025 (USD MILLION) 189
TABLE 199 ROAPAC: DPCR MARKET, BY PRODUCT & SERVICE,
2016–2019 (USD MILLION) 190
TABLE 200 ROAPAC: DPCR MARKET, BY PRODUCT & SERVICE,
2020–2025 (USD MILLION) 190
9.5 LATIN AMERICA 190
TABLE 201 LATIN AMERICA: QPCR MARKET, BY COUNTRY, 2016–2019 (USD MILLION) 191
TABLE 202 LATIN AMERICA: QPCR MARKET, BY COUNTRY, 2020–2025 (USD MILLION) 191
TABLE 203 LATIN AMERICA: DPCR MARKET, BY COUNTRY, 2016–2019 (USD MILLION) 191
TABLE 204 LATIN AMERICA: DPCR MARKET, BY COUNTRY, 2020–2025 (USD MILLION) 192
TABLE 205 LATIN AMERICA: QPCR MARKET, BY PRODUCT & SERVICE,
2016–2019 (USD MILLION) 192
TABLE 206 LATIN AMERICA: QPCR MARKET, BY PRODUCT & SERVICE,
2020–2025 (USD MILLION) 192
TABLE 207 LATIN AMERICA: DPCR MARKET, BY PRODUCT & SERVICE,
2016–2019 (USD MILLION) 193
TABLE 208 LATIN AMERICA: DPCR MARKET, BY PRODUCT & SERVICE,
2020–2025 (USD MILLION) 193
TABLE 209 LATIN AMERICA: QPCR MARKET, BY APPLICATION,
2016–2019 (USD MILLION) 193
TABLE 210 LATIN AMERICA: QPCR MARKET, BY APPLICATION,
2020–2025 (USD MILLION) 194
TABLE 211 LATIN AMERICA: DPCR MARKET, BY APPLICATION,
2016 -2019 (USD MILLION) 194
TABLE 212 LATIN AMERICA: DPCR MARKET, BY APPLICATION,
2020 -2025 (USD MILLION) 194
TABLE 213 LATIN AMERICA: QPCR MARKET, BY END USER, 2016–2019 (USD MILLION) 195
TABLE 214 LATIN AMERICA: QPCR MARKET, BY END USER, 2020–2025(USD MILLION) 195
TABLE 215 LATIN AMERICA: DPCR MARKET, BY END USER, 2016–2019 (USD MILLION) 196
TABLE 216 LATIN AMERICA: DPCR MARKET, BY END USER, 2020–2025 (USD MILLION) 196
9.5.1 BRAZIL 197
9.5.1.1 Brazil dominates the LATAM market 197
TABLE 217 BRAZIL: QPCR MARKET, BY PRODUCT & SERVICE,
2016–2019 (USD MILLION) 197
TABLE 218 BRAZIL: QPCR MARKET, BY PRODUCT & SERVICE,
2020--2025 (USD MILLION) 198
TABLE 219 BRAZIL: DPCR MARKET, BY PRODUCT & SERVICE,
2016–2019 (USD MILLION) 198
TABLE 220 BRAZIL: DPCR MARKET, BY PRODUCT & SERVICE,
2020–2025 (USD MILLION) 198
9.5.2 MEXICO 199
9.5.2.1 Favorable trade agreements will support imports and improve access to dPCR and qPCR instruments in Mexico 199
TABLE 221 MEXICO: QPCR MARKET, BY PRODUCT & SERVICE,
2016–2019 (USD MILLION) 199
TABLE 222 MEXICO: QPCR MARKET, BY PRODUCT & SERVICE,
2020–2025 (USD MILLION) 200
TABLE 223 MEXICO: DPCR MARKET, BY PRODUCT & SERVICE,
2016–2019 (USD MILLION) 200
TABLE 224 MEXICO: DPCR MARKET, BY PRODUCT & SERVICE,
2020–2025 (USD MILLION) 200
9.5.3 REST OF LATIN AMERICA 201
TABLE 225 ROLATAM: QPCR MARKET, BY PRODUCT & SERVICE,
2016–2019 (USD MILLION) 201
TABLE 226 ROLATAM: QPCR MARKET, BY PRODUCT & SERVICE,
2020–2025 (USD MILLION) 201
TABLE 227 ROLATAM: DPCR MARKET, BY PRODUCT & SERVICE,
2016–2019 (USD MILLION) 202
TABLE 228 ROLATAM: DPCR MARKET, BY PRODUCT & SERVICE,
2020–2025 (USD MILLION) 202
9.6 MIDDLE EAST AND AFRICA 203
9.6.1 LOW PURCHASING POWER OF END USERS AND INFRASTRUCTURAL LIMITATIONS TO RESTRAIN MARKET GROWTH IN THE MEA 203
TABLE 229 MIDDLE EAST AND AFRICA: QPCR MARKET, BY PRODUCT & SERVICE,
2016–2019 (USD MILLION) 203
TABLE 230 MIDDLE EAST AND AFRICA: QPCR MARKET, BY PRODUCT & SERVICE,
2020–2025 (USD MILLION) 204
TABLE 231 MIDDLE EAST AND AFRICA: DPCR MARKET, BY PRODUCT & SERVICE,
2016–2019 (USD MILLION) 204
TABLE 232 MIDDLE EAST AND AFRICA: DPCR MARKET, BY PRODUCT & SERVICE,
2017–2024 (USD MILLION) 205
TABLE 233 MIDDLE EAST AND AFRICA: QPCR MARKET, BY APPLICATION,
2016–2019 (USD MILLION) 205
TABLE 234 MIDDLE EAST AND AFRICA: QPCR MARKET, BY APPLICATION,
2020–2025 (USD MILLION) 206
TABLE 235 MIDDLE EAST AND AFRICA: DPCR MARKET, BY APPLICATION,
2016–2019 (USD MILLION) 206
TABLE 236 MIDDLE EAST AND AFRICA: DPCR MARKET, BY APPLICATION,
2020–2025 (USD MILLION) 206
TABLE 237 MIDDLE EAST AND AFRICA: QPCR MARKET, BY END USER,
2016–2019 (USD MILLION) 207
TABLE 238 MIDDLE EAST AND AFRICA: QPCR MARKET, BY END USER,
2020–2025 (USD MILLION) 207
TABLE 239 MIDDLE EAST AND AFRICA: DPCR MARKET, BY END USER,
2016–2020 (USD MILLION) 208
TABLE 240 MIDDLE EAST AND AFRICA: DPCR MARKET, BY END USER,
2020–2025 (USD MILLION) 208
10 COMPETITIVE LANDSCAPE 209
10.1 OVERVIEW 209
FIGURE 20 KEY DEVELOPMENTS BY LEADING MARKET PLAYERS IN THE DPCR
AND QPCR MARKET, 2016–2020 209
10.2 MARKET SHARE ANALYSIS 210
10.2.1 QPCR MARKET SHARE ANALYSIS (2019) 210
FIGURE 21 QPCR MARKET SHARE ANALYSIS, BY KEY PLAYER (2019) 210
10.2.2 DPCR MARKET SHARE ANALYSIS (2019) 210
FIGURE 22 DPCR MARKET SHARE ANALYSIS, BY KEY PLAYER (2019) 210
10.3 COMPETITIVE SCENARIO 211
10.3.1 KEY PRODUCT LAUNCHES, ENHANCEMENTS, AND APPROVALS (2016–2020) 211
10.3.2 KEY PARTNERSHIPS AND COLLABORATIONS (2016–2020) 212
10.3.3 KEY ACQUISITIONS (2016–2020) 213
10.3.4 KEY EXPANSIONS (2016–2020) 214
10.4 DIGITAL PCR AND REAL-TIME (QPCR) MARKET: COMPANY EVALUATION QUADRANT, 2019 215
10.4.1 COMPANY EVALUATION QUADRANT: MAJOR MARKET PLAYERS (2018) 215
10.4.1.1 Stars 215
10.4.1.2 Emerging Leaders 215
10.4.1.3 Pervasive 215
10.4.1.4 Emerging Companies 216
FIGURE 23 GLOBAL COMPANY EVALUATION QUADRANT (OVERALL MARKET) 216
10.4.2 OMPANY EVALUATION QUADRANT: EMERGING COMPANIES/SMES/
START-UPS (2018) 217
10.4.2.1 Progressive Companies 217
10.4.2.2 Starting Blocks 217
10.4.2.3 Responsive Companies 217
10.4.2.4 Dynamic Companies 217
FIGURE 24 COMPANY EVALUATION QUADRANT (SMES/START-UPS) 218

11 COMPANY PROFILES 219
(Business overview, Products and Services offered, Recent developments & MnM View)*
11.1 THERMO FISHER SCIENTIFIC 219
FIGURE 25 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2019) 219
11.2 BIO-RAD LABORATORIES 225
FIGURE 26 BIO-RAD LABORATORIES: COMPANY SNAPSHOT (2019) 225
11.3 ROCHE DIAGNOSTICS 229
FIGURE 27 ROCHE DIAGNOSTICS: COMPANY SNAPSHOT (2019) 229
11.4 ABBOTT LABORATORIES 233
FIGURE 28 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2019) 233
11.5 AGILENT TECHNOLOGIES 236
FIGURE 29 AGILENT TECHNOLOGIES: COMPANY SNAPSHOT (2019) 236
11.6 ANALYTIK JENA AG 240
FIGURE 30 ENDRESS+HAUSER AG: COMPANY SNAPSHOT (2019) 240
11.7 BECTON DICKINSON AND COMPANY 243
FIGURE 31 BECTON DICKINSON AND COMPANY: COMPANY SNAPSHOT (2019) 243
11.8 BIOMÉRIEUX S.A. 245
FIGURE 32 BIOMÉRIEUX S.A.: COMPANY SNAPSHOT (2019) 245
11.9 DANAHER CORPORATION 248
FIGURE 33 DANAHER CORPORATION: COMPANY SNAPSHOT (2019) 248
11.10 EPPENDORF AG 251
FIGURE 34 EPPENDORF AG: COMPANY SNAPSHOT (2019) 251
11.11 FLUIDIGM CORPORATION 253
FIGURE 35 FLUIDIGM CORPORATION: COMPANY SNAPSHOT (2019) 253
11.12 MERCK KGAA 256
FIGURE 36 MERCK KGAA: COMPANY SNAPSHOT (2019) 256
11.13 QIAGEN N.V. 259
FIGURE 37 QIAGEN N.V.: COMPANY SNAPSHOT (2019) 259
11.14 TAKARA BIO 264
FIGURE 38 TAKARA BIO, INC.: COMPANY SNAPSHOT (2019) 264
11.15 MERIDIAN BIOSCIENCE 267
FIGURE 39 MERIDIAN BIOSCIENCE: COMPANY SNAPSHOT (2019) 267
11.16 QUIDEL CORPORATION 270
FIGURE 40 QUIDEL CORPORATION: COMPANY SNAPSHOT (2019) 270
11.17 PROMEGA CORPORATION 272
11.18 ENZO LIFE SCIENCES 274
11.19 BIONEER CORPORATION 276

11.20 ELITECH GROUP 279
11.21 QUANTA BIOSCIENCES 281
11.22 SACACE BIOTECHNOLOGIES S.R.L. 283
11.23 BIO MOLECULAR SYSTEMS 286
11.24 BIOMEME 287
11.25 JN MEDSYS PTE. LTD. 289
11.26 STILLA TECHNOLOGIES 290
11.27 KYRATEC 291
11.28 LGC BIOSEARCH TECHNOLOGIES 292
FIGURE 41 LGC SCIENCE GROUP HOLDINGS LIMITED: COMPANY SNAPSHOT (2019) 292
11.29 COLE-PARMER INSTRUMENT COMPANY 295
11.30 GENOME DIAGNOSTICS PVT. LTD. 297
*Details on Business overview, Products and Services offered, Recent developments & MnM View might not be captured in case of unlisted companies.
12 ADJACENT RELATED MARKET 300
12.1 INTRODUCTION 300
12.2 LIMITATIONS 300
12.3 MOLECULAR DIAGNOSTIC MARKET 300
12.3.1 MARKET DEFINATION 300
12.3.2 MARKET OVERVIEW 300
12.3.3 MOLECULAR DIAGNOSTICS MARKET, BY REGION 301
TABLE 241 MOLECULAR DIAGNOSTICS MARKET, BY REGION,
2016–2023 (USD MILLION) 301
12.3.3.1 North America 301
TABLE 242 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 301
12.3.3.2 Europe 302
TABLE 243 EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY/REGION,
2016–2023 (USD MILLION) 302
12.3.3.3 Asia pacific 302
TABLE 244 ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY/REGION, 2016–2023 (USD MILLION) 302
12.3.3.4 Rest of the World 303
TABLE 245 ROW: MOLECULAR DIAGNOSTICS MARKET, BY REGION,
2016–2023 (USD MILLION) 303
12.4 IN VITRO DIAGNOSTIC (IVD) MARKET 303
12.4.1 MARKET DEFINATION 303
12.4.2 MARKET OVERVIEW 303
12.4.3 IN VITRO DIAGNOSTIC MARKET, BY REGION 304
TABLE 246 IVD MARKET, BY REGION, 2018–2025 (USD MILLION) 304
12.4.3.1 North America 304
TABLE 247 NORTH AMERICA: IVD MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 304
12.4.3.2 Europe 305
TABLE 248 EUROPE: IVD MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 305
12.4.3.3 Asia Pacific 305
TABLE 249 ASIA PACIFIC: IVD MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 305
12.5 LIFE SCIENCE INSTRUMENTATION MARKET 306
12.5.1 MARKET DEFINITION 306
12.5.2 MARKET OVERVIEW 306
12.5.3 LIFE SCIENCE INSTRUMENTATION MARKET, BY REGION 306
TABLE 250 LIFE SCIENCE INSTRUMENTATION MARKET, BY REGION,
2017–2025 (USD MILLION) 306
12.5.3.1 North America 307
TABLE 251 NORTH AMERICA LIFE SCIENCE INSTRUMENTATION MARKET, BY COUNTRY, 2017–2025 (USD MILLION) 307
12.5.3.2 Europe 307
TABLE 252 EUROPE LIFE SCIENCE INSTRUMENTATION MARKET, BY COUNTRY,
2017–2025 (USD MILLION) 307
12.5.3.3 Asia Pacific 308
TABLE 253 ASIA PACIFIC LIFE SCIENCE INSTRUMENTATION MARKET, BY COUNTRY, 2017–2025 (USD MILLION) 308
13 APPENDIX 309
13.1 DISCUSSION GUIDE 309
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 313
13.3 AVAILABLE CUSTOMIZATIONS 315
13.4 RELATED REPORTS 315
13.5 AUTHOR DETAILS 316

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界のデジタルPCR(dPCR)・リアルタイムPCR(qPCR)市場予測(~2025年):製品別(機器、試薬・消耗品、ソフトウェア・サービス)、用途別(臨床、研究、法医学)、エンドユーザー別(病院・診断センター、製薬バイオテクノロジー、CRO)]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆